Back to search

University of British Columbia

Perinatal outcomes in multiple sclerosis

Abstract

dc:description

Multiple sclerosis (MS) is a putative autoimmune disease of the central nervous system, affecting many adults of childbearing age. Although extensive research has examined the association between MS and traditional perinatal outcomes (i.e. cesarean section, birth weight and preterm birth), other important outcomes are understudied, partly due to existing methodological challenges. Using comprehensive populationbased databases including the British Columbia (BC) MS Database, BC Perinatal Database Registry, Vital Statistics Birth Registry, Population Data BC Consolidation File and Census GeoData, this dissertation investigated the association between MS (and related clinical factors) with: labour induction and augmentation; obstetrical epidural and spinal anesthesia; length of birth hospitalization in mothers and their newborns; as well as birth outcomes in fathers with MS. Overall, individuals with MS were not at increased risk for the investigated outcomes compared to the general population with the exception that multiparous women with MS had higher rates of epidural anesthesia compared to multiparous women in the general population. Within MS women, those with longer disease duration had less epidural anesthesia and those with greater disability had more labor induction. Men with greater MS disability tended to father offspring with lower mean birth weight, but their newborns were still within the normal range for the general population. Individuals with MS who wish to have children must also decide between initiating disease-modifying drug (DMD) early to minimize relapses (i.e. MS attacks) or delaying/stopping therapy prior to conception to avoid potential fetal harm from in utero DMD exposure. This dissertation explored perinatal outcomes in women and men with iii MS exposed to DMDs and includes a systematic review of DMD exposure on perinatal outcomes. Data from BC suggest that DMD exposure in men and women with MS does not increase the risk of unfavorable perinatal outcomes. However, best evidence from the systematic review indicates that interferon-beta exposure in women with MS is associated with preterm birth, lower mean birth weight and shorter mean birth length in newborns; nonetheless, growth parameters of exposed newborns remained within normal values for the general population and preterm births tended to be close to term.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lu, Ellen Meng-I

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial 3.0 Unported
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/44199

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Lu, Ellen Meng-I. Perinatal outcomes in multiple sclerosis. doctoral thesis, University of British Columbia, 2013. http://hdl.handle.net/2429/44199